Table 1.
‘Before-to-during’ syphilis infectiona | ‘During-to-after’ syphilis infectionb | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Category | No. | Direction of change +/0/−c | Mean | Median | P | No. | Direction of change +/0/− | Mean | Median | P |
Change in HIV-RNA levelsd (log10 copies/ml) | ||||||||||
Overall | 36 | 15/10/11 | 0.21 | 0.00 | 0.02 | 35 | 13/7/15 | −0.10 | 0.00 | 0.52 |
Stage of syphilis | ||||||||||
Primary | 14 | 4/4/6 | 0.02 | 0.00 | 1.00 | 10 | 3/1/6 | −0.05 | −0.10 | 0.82 |
Secondary | 22 | 11/6/5 | 0.33 | 0.25 | 0.01 | 25 | 10/6/9 | −0.10 | 0.00 | 0.65 |
Antiretroviral use | ||||||||||
On HAART | 21 | 7/8/6 | 0.19 | 0.00 | 0.19 | 24 | 10/6/8 | −0.05 | 0.00 | 0.97 |
Not on HAARTe | 15 | 8/2/5 | 0.25 | 0.51 | 0.09 | 11 | 3/1/7 | −0.18 | −0.06 | 0.23 |
Viral load level | ||||||||||
Detectable | 26 | 13/2/11 | 0.20 | 0.16 | 0.07 | 28 | 12/1/15 | −0.11 | −0.06 | 0.48 |
Undetectable | 10 | 2/8/0 | 0.25 | 0.00 | 0.50 | 7 | 1/6/0 | −0.08 | 0.00 | 1.00 |
CD4 cell count | ||||||||||
≥ 350 cells/mm3 | 14 | 6/7/1 | 0.24 | 0.00 | 0.16 | 19 | 9/3/7 | −0.09 | 0.00 | 0.98 |
< 350 cells/mm3 | 21 | 8/3/10 | 0.16 | 0.00 | 0.32 | 16 | 4/4/8 | −0.08 | −0.03 | 0.46 |
Change in CD4 cell count (cells/mm3) | ||||||||||
Overall | 31 | 12/0/19 | −62 | −16 | 0.04 | 31 | 20/0/11 | 33 | 30 | 0.23 |
Stage of syphilis | ||||||||||
Primary | 12 | 4/0/8 | −36 | −12 | 0.21 | 11 | 7/0/4 | 24 | 34 | 0.62 |
Secondary | 19 | 8/0/11 | −78 | −144 | 0.11 | 20 | 13/0/7 | 38 | 30 | 0.12 |
Antiretroviral use | ||||||||||
On HAART | 19 | 9/0/10 | −32 | −16 | 0.31 | 22 | 15/0/7 | 54 | 32 | 0.05 |
Not on HAART | 12 | 3/0/9 | −110 | −45 | 0.03 | 9 | 5/0/2 | −18 | 14 | 1.00 |
Viral load level | ||||||||||
Detectable | 21 | 8/0/13 | −79 | −15 | 0.06 | 24 | 15/0/9 | 8 | 32 | 0.29 |
Undetectable | 10 | 4/0/6 | −27 | −119 | 0.49 | 7 | 5/0/2 | 119 | 30 | 0.30 |
CD4 cell count | ||||||||||
≥ 350 cells/mm3 | 13 | 4/0/9 | −64 | −88 | 0.21 | 14 | 9/0/5 | 16 | 28 | 0.76 |
< 350 cells/mm3 | 18 | 8/0/10 | −60 | −16 | 0.14 | 17 | 11/0/6 | 47 | 34 | 0.05 |
HAART, Highly active antiretroviral therapy.
The median timespan for ‘before-to-during’ changes in 36 men was 6.2 months.
The median timespan for ‘during-to-after’ changes in 35 men was 4.2 months.
Indicates how many men had an increase, no change or decrease in measurements.
Mean and median values are subject to some viral load values being below the limit of detection and truncated, as described in the text. P values obtained by Wilcoxon signed rank test.
Indicates men who were not receiving antiretroviral therapy.